{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:57:06Z","timestamp":1780498626848,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ymgmr.2020.100676","type":"journal-article","created":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T09:26:44Z","timestamp":1605346004000},"page":"100676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The juvenile gangliosidoses: A timeline of clinical change"],"prefix":"10.1016","volume":"25","author":[{"given":"Kelly E.","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester B.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine R.","family":"Jarnes-Utz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ymgmr.2020.100676_bb0005","first-page":"663","article-title":"The GM1 and GM2 gangliosidoses: natural history and progress toward therapy pediatric endocrinology reviews","volume":"13","author":"Regier","year":"2016","journal-title":"PER"},{"key":"10.1016\/j.ymgmr.2020.100676_bb0010","series-title":"Pediatric Endocrinology and Inborn Errors of Metabolism","author":"Sarafoglou","year":"2009"},{"key":"10.1016\/j.ymgmr.2020.100676_bb0015","series-title":"Lysosomal Storage Disorders","author":"Barranger","year":"2007"},{"key":"10.1016\/j.ymgmr.2020.100676_bb0020","doi-asserted-by":"crossref","first-page":"e1550","DOI":"10.1542\/peds.2006-0588","article-title":"The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported","volume":"118","author":"Maegawa","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgmr.2020.100676_bb0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ymgme.2017.04.011","article-title":"Infantile gangliosidoses: mapping a timeline of clinical changes","volume":"121","author":"Jarnes-Utz","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2020.100676_bb0030","doi-asserted-by":"crossref","first-page":"e1233","DOI":"10.1542\/peds.2011-0078","article-title":"Natural history of infantile G(M2) gangliosidosis","volume":"128","author":"Bley","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgmr.2020.100676_bb0035","first-page":"115","article-title":"Clinical Findings and Natural History in Ten Unrelated Families with Juvenile and Adult GM1","volume":"24","author":"Kannebley","year":"2015","journal-title":"Gangliosidosis JIMD Rep."},{"key":"10.1016\/j.ymgmr.2020.100676_bb0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1469-8749.2011.04160.x","article-title":"GM2 gangliosidosis in a UK study of children with progressive neurodegeneration: 73 cases reviewed","volume":"54","author":"Smith","year":"2012","journal-title":"Develop. Med. Child Neurol."},{"key":"10.1016\/j.ymgmr.2020.100676_bb0045","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.braindev.2018.01.009","article-title":"Diagnostic challenge for the rare lysosomal storage disease: Late infantile GM1 gangliosidosis","volume":"40","author":"Lee","year":"2018","journal-title":"Brain Develop."},{"key":"10.1016\/j.ymgmr.2020.100676_bb0050","first-page":"634","article-title":"MRI\/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis American journal of medical genetics","volume":"170","author":"Regier","year":"2016","journal-title":"Part A"},{"key":"10.1016\/j.ymgmr.2020.100676_bb0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pediatrneurol.2013.02.003","article-title":"GM1 gangliosidosis, late infantile onset dystonia, and T2 Hypointensity in the globus pallidus and substantia Nigra","volume":"49","author":"Vieira","year":"2013","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgmr.2020.100676_bb0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13312-015-0593-2","article-title":"White matter changes in GM1 gangliosidosis","volume":"52","author":"Tuteja","year":"2015","journal-title":"Ind. Pediatr."},{"key":"10.1016\/j.ymgmr.2020.100676_bb0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.33588\/rn.2905.99302","article-title":"Late infantile and juvenile form of GM2-gangliosidosis variant B1","volume":"29","author":"Eiris","year":"1999","journal-title":"Revista de neurologia"},{"key":"10.1016\/j.ymgmr.2020.100676_bb0070","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF02723030","article-title":"Ptosis in late infantile Tay-Sachs disease","volume":"68","author":"Devidayal","year":"2001","journal-title":"Ind. J.Pediatr."},{"key":"10.1016\/j.ymgmr.2020.100676_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ymgme.2017.12.432","article-title":"Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study","volume":"123","author":"Nestrasil","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2020.100676_bb0080","author":"Bayley"},{"key":"10.1016\/j.ymgmr.2020.100676_bb0085","author":"Kaufman"},{"key":"10.1016\/j.ymgmr.2020.100676_bb0090","author":"Roman"},{"key":"10.1016\/j.ymgmr.2020.100676_bb0095","series-title":"Vineland-II : Vineland Adaptive Behavior Scales : Survey Forms Manual","author":"Sparrow","year":"2005"},{"key":"10.1016\/j.ymgmr.2020.100676_bb0100","series-title":"Vineland Adaptive Behavior Scales: Vineland-III : Manual","author":"Sparrow","year":"2016"},{"key":"10.1016\/j.ymgmr.2020.100676_bb0105","series-title":"Summary of Product Characteristics","author":"Miglustat","year":"2012"},{"key":"10.1016\/j.ymgmr.2020.100676_bb0110","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ymgme.2009.04.013","article-title":"Pharmacokinetics, safety and tolerability of miglustat in the treatment of pediatric patients with GM2 gangliosidosis","volume":"97","author":"Maegawa","year":"2009","journal-title":"Mol. Genet.Metab."},{"key":"10.1016\/j.ymgmr.2020.100676_bb0115","doi-asserted-by":"crossref","first-page":"115142","DOI":"10.1016\/j.bone.2019.115142","article-title":"The skeletal phenotype of intermediate GM1 gangliosidosis: clinical, radiographic and densitometric features, and implications for clinical monitoring and intervention","volume":"131","author":"Ferreira","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.ymgmr.2020.100676_bb0120","first-page":"129","article-title":"Methods of neurodevelopmental assessment in children with neurodegenerative disease: Sanfilippo syndrome","volume":"13","author":"Delaney","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgmr.2020.100676_bb0125","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2019.12.012","article-title":"The natural history of Type 1 infantile GM1 gangliosidosis: a literature-based meta-analysis","volume":"129","author":"Lang","year":"2020","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426920301221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426920301221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:51:42Z","timestamp":1762001502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426920301221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":25,"alternative-id":["S2214426920301221"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100676","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The juvenile gangliosidoses: A timeline of clinical change","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2020.100676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100676"}}